Bone marrow-derived mesenchymal stem cell and simvastatin treatment leads to improved functional recovery and modified c-Fos expression levels in the brain following ischemic stroke

OBJECTIVE(S): The beneficial outcomes of bone marrow-derived mesenchymal stem cell (BMSC) treatment on functional recovery following stroke has been well established. Furthermore, 5-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors have also been shown to increase neuronal survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Pirzad Jahromi, Gila, P Shabanzadeh, Alireza, Mokhtari Hashtjini, Mina, Sadr, Seyed Shahabeddin, Rasouli Vani, Javad, Raouf Sarshoori, Javad, Charish, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281073/
https://www.ncbi.nlm.nih.gov/pubmed/30524673
http://dx.doi.org/10.22038/IJBMS.2018.29382.7100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281073/
https://www.ncbi.nlm.nih.gov/pubmed/30524673
http://dx.doi.org/10.22038/IJBMS.2018.29382.7100

Ejemplares similares